Blog / Archives
Rayno SnowBlog: LaNina Advisory-Nat Gas Up on Cold Weather- Update
11/23/10 Nat Gas is approaching its mid-Sep highs as cold weather is forecasted to continue for the next 10-14 days. Today's high is $4.29 up from lows around $3.70 on Oct 25. The Jan.'11 Futures...
Microfluidics (MFLU.OB) Revenues Down 9% but Value Play Intact
Microfluidics reported revenues of $4.1M for Q3 2010 ended Sep 30 a decrease of 9% or $500k compared to the same period of 2009. Excluding revenues of $1.3M attributed to machine production of the...
Rayno Life Science Portfolio Update: BLUD,ILMN, NEOG,SQNM
Immucor (BLUD) stock was up 5.7% to $18.91 on news that the DOJ closed its anti-trust investigation. The stock hit a low in early October when it slashed guidance due to lower utility of blood...
Cardiovascular Systems (CSII) Gains Traction-Good Value Play
Cardiovascular Systems(CSII) is a medical device Company that focuses on interventional treatment for peripheral arterial disease(PAD). The primary products are the Diamondback 360 and the Predator...
RaynoLifeScience Portfolio: Earnings Update-ABAX,GPRO
Abaxis (ABAX) beat estimates with reported Q3 Revenues of $35.3M/$0.17 up 17% over last year's comparable quarter. Cash position is $100.6M up from $87.6M last year's Q3. March '11 Fiscal Year...
Trading Update:Exact Sciences (EXAS) Reports Positive Data for Colorectal Cancer Test
EXAS -Big Sell-Off on the News Exact Sciences (EXAS) was down 20% today after presenting its first validation data on the performance of its experimental, non-invasive colorectal cancer test. As of...
Great Day for Biotech Tools:Earnings Up ILMN,LIFE and PacBio (PACB) IPO
Timing is everything and Pacific Biosciences(PACB) took advantage of a good year for biotech stocks, better earnings for tools and Dx companies and a rebounding IPO market. Pacific Biosciences...
GE Buys Oncology Diagnostic Co. Clarient (CLRT)-Update- Dx Movers
GE announced the purchase of Clarient (CLRT) for $5/share or $580M, a 34% premium over Clarient's previous closing price. Revenues forecasted for 2011 and 2012 are at $114M and $136M respectively,...
Rayno Life Science Portfolio Big Movers: Gilead (GILD),Supergen (SUPG)
Risk is on today due to a weak dollar and that is usually good for Life Science stocks.MidCap biotechs are mainly green despite bad news from Amylin (AMLN) $11.35 down 44%, and partner Alkermes...
Rayno Life Science Portfolio Notes- Q3 Earnings in Two weeks
The Rayno Life Science Portfolio is up 20% and later this month we will see important earnings reports from tools and diagnostics companies. Life Science stocks are outperforming the NASDAQ and...